| 2008 JASN IMPACT FACTOR 7.505 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CLINICAL RESEARCH |






*Vanderbilt University Medical Center, Department of Medicine, Division of Nephrology, Nashville, Tennessee;
Vanderbilt University Medical Center, Department of Medicine, Division of Allergy, Pulmonary, and Critical Care Medicine, Nashville, Tennessee;
Vanderbilt University Medical Center, Department of Biostatistics, Nashville, Tennessee;
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
Correspondence: Dr. T. Alp Ikizler, Vanderbilt University Medical Center, 1161 21st Avenue South/MCN S-3312, Nashville, TN 37232. Phone: 615-343-6104; Fax: 615-343-7156; E-mail: Alp.ikizler{at}vanderbilt.edu
Received for publication July 2, 2008. Accepted for publication April 1, 2009.
Urine neutrophil gelatinase-associated lipocalin (uNGAL) has shown promise as a biomarker for the early detection of acute kidney injury (AKI) in fixed models of injury, but its ability to predict AKI and provide prognostic information in critically ill adults is unknown. We prospectively studied a heterogeneous population of 451 critically ill adults, 64 (14%) and 86 (19%) of whom developed AKI within 24 and 48 h of enrollment, respectively. Median uNGAL at enrollment was higher among patients who developed AKI within 48 h compared with those who did not (190 versus 57 ng/mg creatinine, P < 0.001). The areas under the receiver operating characteristic curves describing the relationship between uNGAL level and the occurrence of AKI within 24 and 48 h were 0.71 (95% Confidence Intervals [CI]: 0.63 to 0.78) and 0.64 (95% CI: 0.57 to 0.71), respectively. Urine neutrophil gelatinase-associated lipocalin remained independently associated with the development of AKI after adjustment for age, serum creatinine closest to enrollment, illness severity, sepsis, and intensive care unit (ICU) location, although it only marginally improved the predictive performance of the clinical model alone. A Cox proportional hazards model using time to first dialysis, adjusted for APACHE II score, suggested that uNGAL independently predicts severe AKI during hospitalization [HR 2.60, 95% CI:1.55 to 4.35]. In summary, although a single measurement of uNGAL exhibited moderate predictive utility for the development and severity of AKI in a heterogeneous ICU population, its additional contribution to conventional clinical risk predictors appears limited.
Related Articles
J. Am. Soc. Nephrol. 2009 20: A12.
J. Am. Soc. Nephrol. 2009 20: 1656-1657.
This article has been cited by other articles:
![]() |
P. J. Nelson and L. Cantley GSK3{beta} Plays Dirty in Acute Kidney Injury J. Am. Soc. Nephrol., February 1, 2010; 21(2): 199 - 200. [Full Text] [PDF] |
||||
![]() |
L. A. Szczech The Development of Urinary Biomarkers for Kidney Disease Is the Search for Our Renal Troponin J. Am. Soc. Nephrol., August 1, 2009; 20(8): 1656 - 1657. [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2009 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673